PTGS2 (COX2) 2765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5219-5224

  Daraei, Abdolreza ^a   Salehi, Rasoul ^a   Mohamadhashem, Faezeh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

PTGS2 765G>C polymorphism; Sporadic colorectal cancer

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; GLYCINE; NONSTEROID ANTIINFLAMMATORY AGENT; PTGS2 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DRUG USE; ETHNIC GROUP; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION RISK; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; CASE CONTROL STUDY; COLORECTAL TUMOR; DEMOGRAPHY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MOLECULAR GENETICS; RISK FACTOR;

BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DEMOGRAPHY; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84863766276     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1319-8     Document Type: Article

References (34)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365:153-165
2. Hajdu SI (2006) Thoughts about the cause of cancer. Cancer 106:1643-1649. doi:10.1002/cncr
3. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916-932
4. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780
5. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544-573. doi:10.1002/cncr
6. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58:71-96
7. Butterly LF, Goodrich M, Onega T, Greene MA, Srivastava A, Burt R, Dietrich A (2010) Improving the quality of colorectal cancer screening: assessment of familial risk. Dig Dis Sci 55:754-760. doi:10.1007/s10620-009- 1058-z
8. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R (2009) Epidemiology and molecular genetics of colorectal cancer in Iran: a review. Arch Iran Med 12:161-169
9. Pahlavan PS, Kanthan R (2006) The epidemiology and clinical findings of colorectal cancer in Iran. J Gastrointest Liver Dis 15:15-19
10. Aiello M, Vella N, Cannavo C, Scalisi A, Spandidos DA, Toffoli G, Buonadonna A, Libra M, Stivala F (2010) Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep 4:203-208. doi:10.3892/mmr
11. Daraei A, Salehi R, Salehi M, Emami MH, Jonghorbani M, Mohamadhashem F and Tavakoli H (2011) Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Med Oncol. doi:10.1007/s12032-011-9980-2
12. Thompson CL, Plummer SJ, Merkulova A, Cheng I, Tucker TC, Casey G, Li L (2009) No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol 15:2240-2244
13. Iglesias D, Nejda N, Azcoita MM, Schwartz S Jr, Gonzalez-Aguilera JJ, Fernandez-Peralta AM (2009) Effect of COX2 -765G[C and c.3618A[G polymorphisms on the risk and survival of sporadic colorectal cancer.Cancer Causes Control 20:1421-1429. doi:10.1007/ s10552-009-9368-1
14. Williams CS, Mann M, DuBois RN (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908-7916. doi:10.1038/sj.onc.1203286
15. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Du Bois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188
16. Mariani F, Sena P, Marzona L, Riccio M, Fano R, Manni P, Gregorio CD, Pezzi A, Leon MP, Monni S, Pol AD, Roncucci L (2009) Cyclooxygenase-2 and hypoxia-inducible factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 279:221-229
17. Trifan OC, Hla T (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7:207-222
18. Bosetti C, Gallus S, La Vecchia C (2006) Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 17:871-888. doi:10.1007/s10552-006-0033-7
19. Westbrook AM, Szakmary A, Schiestl RH (2010) Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res 705:40-59
20. Fornai M, Antonioli L, Colucci R, Bernardini N, Ghisu N, Tuccori M, De Giorgio R, Del Tacca M, Blandizzi C (2010) Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions. Pharmacol Ther 125: 62-78
21. Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F, Moreno V (2004) Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 91:339-343. doi:10.1038/sj.bjc. 6601906
22. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25:2467-2472. doi:10.1093/carcin/bgh260
23. Zhu W, Wei BB, Shan X, Liu P (2010) 765G[C and 8473T[C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies. Mol Biol Rep 37:277-288. doi: 10.1007/s11033-009-9685-1
24. Cao H, Xu Z, Long H, Li XQ, Li SL (2010) The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis. Tohoku J Exp Med 222:15-21
25. Ahmed FE (2006) Gene-gene, gene-environment and multiple interactions in colorectal cancer. J Environ Sci Health C 24: 1-101
26. Gong Z, Bostick RM, Xie D, Hurley TG, Deng Z, Dixon DA, Zhang J, Hebert JR (2009) Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma. Int J Colorectal Dis 24:647-654. doi:10.1007/ s00384-009-0656-8
27. Koh WP, Yuan JM, van den Berg D, Lee HP, Yu MC (2004) Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese health study. Br J Cancer 90:1760-1764. doi: 10.1038/sj.bjc.6601797
28. Tan W, Wu J, Zhang X, Guo Y, Liu J, Sun T, Zhang B, Zhao D, Yang M, Yu D, Lin D (2007) Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 28:1197-1201
29. Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J (2005) PTGS2 (COX-2) -765G[C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 14:616-619
30. Ben Nasr H, Chahed K, Bouaouina N, Chouchane L (2009) PTGS2 (COX-2) -765G[C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 36:193-200. doi: 10.1007/s11033-007-9166-3
31. Harris RE, Beebe-Donk J, Doss H, Burr Doss D (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 13:559-583
32. Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X (2008) Cyclooxygenase 2 polymorphism and colorectal cancer: -765G[C variant modifies risk associated with smoking and body mass index. World J Gastroenterol 14:1785-1789
33. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129: 565-576
34. Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS (2007) COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br J Cancer 97:557-561